相关实验视频
Updated: Jul 25, 2025

08:12
Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
Published on: October 5, 2020
3.1K
K-Ras结合了与卡尔莫杜林相关的Centrin1,这对K-Ras驱动的癌细胞干细胞症有潜在的影响
Ganesh Babu Manoharan1, Christina Laurini1, Sara Bottone1
1Cancer Cell Biology and Drug Discovery Group, Department of Life Sciences and Medicine, University of Luxembourg, L-4362 Esch-sur-Alzette, Luxembourg.
Cancers
|June 28, 2023
概括
结合蛋白Centrin1与K-Ras相互作用,在癌症中可能与calmodulin (CaM) 共享功能. 这两种蛋白质都与K-Ras结合,而致癌形式的相互作用增加,这表明细胞过程中的重叠作用.
科学领域:
- 分子和细胞生物学分子和细胞生物学
- 在瘤学瘤学.
- 信号传输 信号传输
背景情况:
- K-Ras4B (K-Ras) 参与通过卡尔莫杜林 (CaM) 依赖的非正规Wnt信号传递来驱动癌细胞干细胞.
- 其他结合蛋白的作用,如中心蛋白1,在调解K-Ras功能方面仍然在很大程度上未被探索.
研究的目的:
- 为了研究中心素1是否与K-Ras.结合.
- 确定 centrin1 是否可以调解以前归因于 CaM 的 K-Ras 功能.
- 为了比较K-Ras,CaM和中心蛋白之间的结合相互作用和功能重叠1.
主要方法:
- 细胞BRET (生物发光共振能量转移) 试验.
- 免疫沉实验. 免疫沉的实验.
- 在各种条件下,包括突变和抑制剂治疗,分析K-Ras与CaM和centrin1结合的分析.
主要成果:
- 在细胞中,CaM和centrin1都与K-Ras结合,CaM表现出更强的结合,特别是与K-Ras的C端膜.
- 致癌的K-RasG12V表现出对CaM和Centrin1的结合增加,这取决于效应因子相互作用.
- CaM 抑制剂破坏了K-RasG12V-centrin1的相互作用,这表明功能交叉声.
结论:
- Centrin1与K-Ras相互作用,这表明功能与CaM的潜在重叠.
- K-Ras的G域与CaM和centrin1.1一起参与其复杂的形成.
- 这些发现突显了K-Ras的CaM和中枢蛋白1依赖功能的显著重叠,这对癌症生物学有意义.
相关概念视频
The Ras Gene
6.3K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.3K
Small GTPases - Ras and Rho
4.0K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
4.0K
MAPK Signaling Cascades
5.7K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.7K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Calmodulin-dependent Signaling
5.2K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.2K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K

